Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Inozyme Pharma Inc (NASDAQ: INZY) was $3.95 for the day, down -1.00% from the previous closing price of $3.99. In other words, the price has decreased by -$1.00 from its previous closing price. On the day, 6.34 million shares were traded. INZY stock price reached its highest trading level at $3.97 during the session, while it also had its lowest trading level at $3.94.
Ratios:
Our analysis of INZY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 1.48 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on December 12, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On September 12, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’25 when Treco Douglas A sold 8,819 shares for $0.89 per share. The transaction valued at 7,849 led to the insider holds 41,046 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INZY now has a Market Capitalization of 255019120 and an Enterprise Value of 217197200.
Stock Price History:
The Beta on a monthly basis for INZY is 2.46, which has changed by -0.15598291 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, INZY has reached a high of $6.24, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is 224.10%, while the 200-Day Moving Average is calculated to be 35.23%.
Shares Statistics:
INZY traded an average of 1.74M shares per day over the past three months and 7703370 shares per day over the past ten days. A total of 64.47M shares are outstanding, with a floating share count of 43.53M. Insiders hold about 32.58% of the company’s shares, while institutions hold 49.48% stake in the company. Shares short for INZY as of 1745971200 were 3985553 with a Short Ratio of 2.30, compared to 1743379200 on 4206464. Therefore, it implies a Short% of Shares Outstanding of 3985553 and a Short% of Float of 6.670000399999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.23 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$1.13 and -$1.43 for the fiscal current year, implying an average EPS of -$1.24. EPS for the following year is -$0.98, with 3.0 analysts recommending between -$0.76 and -$1.25.
